drugset / Trial / NCT00206219
Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is to compare ZD1839 (250mg and 500mg) versus methotrexate in head and neck cancer in terms of overall survival.
Timeline
- Start
- 2003-11
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gefitinib | Small molecule | 250 mg | — |
| Subject | Gefitinib | Small molecule | 500 mg | — |
| Subject | Methotrexate | Small molecule | — | — |